nodes	percent_of_prediction	percent_of_DWPC	metapath
Metaxalone—Haemolytic anaemia—Melphalan—peripheral nervous system neoplasm	0.0239	0.0239	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Topotecan—peripheral nervous system neoplasm	0.0227	0.0227	CcSEcCtD
Metaxalone—Irritability—Tretinoin—peripheral nervous system neoplasm	0.0208	0.0208	CcSEcCtD
Metaxalone—Irritability—Isotretinoin—peripheral nervous system neoplasm	0.0208	0.0208	CcSEcCtD
Metaxalone—Abdominal discomfort—Tretinoin—peripheral nervous system neoplasm	0.0181	0.0181	CcSEcCtD
Metaxalone—Abdominal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.0181	0.0181	CcSEcCtD
Metaxalone—Drowsiness—Tretinoin—peripheral nervous system neoplasm	0.0168	0.0168	CcSEcCtD
Metaxalone—Drowsiness—Isotretinoin—peripheral nervous system neoplasm	0.0168	0.0168	CcSEcCtD
Metaxalone—Jaundice—Melphalan—peripheral nervous system neoplasm	0.0162	0.0162	CcSEcCtD
Metaxalone—Irritability—Alitretinoin—peripheral nervous system neoplasm	0.0158	0.0158	CcSEcCtD
Metaxalone—Haemolytic anaemia—Cisplatin—peripheral nervous system neoplasm	0.0156	0.0156	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Cisplatin—peripheral nervous system neoplasm	0.0146	0.0146	CcSEcCtD
Metaxalone—Abdominal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.0137	0.0137	CcSEcCtD
Metaxalone—Irritability—Cisplatin—peripheral nervous system neoplasm	0.0134	0.0134	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Etoposide—peripheral nervous system neoplasm	0.0133	0.0133	CcSEcCtD
Metaxalone—Tension—Isotretinoin—peripheral nervous system neoplasm	0.0129	0.0129	CcSEcCtD
Metaxalone—Tension—Tretinoin—peripheral nervous system neoplasm	0.0129	0.0129	CcSEcCtD
Metaxalone—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.0128	0.0128	CcSEcCtD
Metaxalone—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.0128	0.0128	CcSEcCtD
Metaxalone—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.0127	0.0127	CcSEcCtD
Metaxalone—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.0119	0.0119	CcSEcCtD
Metaxalone—Abdominal discomfort—Cisplatin—peripheral nervous system neoplasm	0.0117	0.0117	CcSEcCtD
Metaxalone—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.0116	0.0116	CcSEcCtD
Metaxalone—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.0108	0.0108	CcSEcCtD
Metaxalone—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.0107	0.0107	CcSEcCtD
Metaxalone—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.0107	0.0107	CcSEcCtD
Metaxalone—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.0106	0.0106	CcSEcCtD
Metaxalone—Tension—Alitretinoin—peripheral nervous system neoplasm	0.00977	0.00977	CcSEcCtD
Metaxalone—Jaundice—Etoposide—peripheral nervous system neoplasm	0.0097	0.0097	CcSEcCtD
Metaxalone—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.00967	0.00967	CcSEcCtD
Metaxalone—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00961	0.00961	CcSEcCtD
Metaxalone—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00953	0.00953	CcSEcCtD
Metaxalone—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00953	0.00953	CcSEcCtD
Metaxalone—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00859	0.00859	CcSEcCtD
Metaxalone—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00813	0.00813	CcSEcCtD
Metaxalone—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00796	0.00796	CcSEcCtD
Metaxalone—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.0079	0.0079	CcSEcCtD
Metaxalone—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.0079	0.0079	CcSEcCtD
Metaxalone—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00783	0.00783	CcSEcCtD
Metaxalone—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.0078	0.0078	CcSEcCtD
Metaxalone—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00765	0.00765	CcSEcCtD
Metaxalone—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00759	0.00759	CcSEcCtD
Metaxalone—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00759	0.00759	CcSEcCtD
Metaxalone—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00759	0.00759	CcSEcCtD
Metaxalone—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00749	0.00749	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00748	0.00748	CcSEcCtD
Metaxalone—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00722	0.00722	CcSEcCtD
Metaxalone—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00715	0.00715	CcSEcCtD
Metaxalone—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00709	0.00709	CcSEcCtD
Metaxalone—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00709	0.00709	CcSEcCtD
Metaxalone—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00696	0.00696	CcSEcCtD
Metaxalone—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00692	0.00692	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.00692	0.00692	CcSEcCtD
Metaxalone—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00687	0.00687	CcSEcCtD
Metaxalone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00682	0.00682	CcSEcCtD
Metaxalone—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00682	0.00682	CcSEcCtD
Metaxalone—Rash—Topotecan—peripheral nervous system neoplasm	0.00682	0.00682	CcSEcCtD
Metaxalone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00681	0.00681	CcSEcCtD
Metaxalone—Headache—Topotecan—peripheral nervous system neoplasm	0.00677	0.00677	CcSEcCtD
Metaxalone—Rash—Tretinoin—peripheral nervous system neoplasm	0.00676	0.00676	CcSEcCtD
Metaxalone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00676	0.00676	CcSEcCtD
Metaxalone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00675	0.00675	CcSEcCtD
Metaxalone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00675	0.00675	CcSEcCtD
Metaxalone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00673	0.00673	CcSEcCtD
Metaxalone—Headache—Tretinoin—peripheral nervous system neoplasm	0.00672	0.00672	CcSEcCtD
Metaxalone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00672	0.00672	CcSEcCtD
Metaxalone—Rash—Melphalan—peripheral nervous system neoplasm	0.00667	0.00667	CcSEcCtD
Metaxalone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00667	0.00667	CcSEcCtD
Metaxalone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00646	0.00646	CcSEcCtD
Metaxalone—Nausea—Topotecan—peripheral nervous system neoplasm	0.00642	0.00642	CcSEcCtD
Metaxalone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00637	0.00637	CcSEcCtD
Metaxalone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00637	0.00637	CcSEcCtD
Metaxalone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00634	0.00634	CcSEcCtD
Metaxalone—Nausea—Melphalan—peripheral nervous system neoplasm	0.00629	0.00629	CcSEcCtD
Metaxalone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00599	0.00599	CcSEcCtD
Metaxalone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00577	0.00577	CcSEcCtD
Metaxalone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00575	0.00575	CcSEcCtD
Metaxalone—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00564	0.00564	CcSEcCtD
Metaxalone—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00558	0.00558	CcSEcCtD
Metaxalone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00557	0.00557	CcSEcCtD
Metaxalone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00553	0.00553	CcSEcCtD
Metaxalone—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00543	0.00543	CcSEcCtD
Metaxalone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00537	0.00537	CcSEcCtD
Metaxalone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00521	0.00521	CcSEcCtD
Metaxalone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00518	0.00518	CcSEcCtD
Metaxalone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00517	0.00517	CcSEcCtD
Metaxalone—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00516	0.00516	CcSEcCtD
Metaxalone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00512	0.00512	CcSEcCtD
Metaxalone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00512	0.00512	CcSEcCtD
Metaxalone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.0051	0.0051	CcSEcCtD
Metaxalone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00509	0.00509	CcSEcCtD
Metaxalone—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00503	0.00503	CcSEcCtD
Metaxalone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00498	0.00498	CcSEcCtD
Metaxalone—Rash—Vincristine—peripheral nervous system neoplasm	0.00494	0.00494	CcSEcCtD
Metaxalone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00493	0.00493	CcSEcCtD
Metaxalone—Headache—Vincristine—peripheral nervous system neoplasm	0.00491	0.00491	CcSEcCtD
Metaxalone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00483	0.00483	CcSEcCtD
Metaxalone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00467	0.00467	CcSEcCtD
Metaxalone—Nausea—Vincristine—peripheral nervous system neoplasm	0.00465	0.00465	CcSEcCtD
Metaxalone—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00449	0.00449	CcSEcCtD
Metaxalone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.0044	0.0044	CcSEcCtD
Metaxalone—Rash—Cisplatin—peripheral nervous system neoplasm	0.00437	0.00437	CcSEcCtD
Metaxalone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00436	0.00436	CcSEcCtD
Metaxalone—Tension—Epirubicin—peripheral nervous system neoplasm	0.00428	0.00428	CcSEcCtD
Metaxalone—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.00423	0.00423	CcSEcCtD
Metaxalone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00419	0.00419	CcSEcCtD
Metaxalone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00411	0.00411	CcSEcCtD
Metaxalone—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00403	0.00403	CcSEcCtD
Metaxalone—Rash—Etoposide—peripheral nervous system neoplasm	0.004	0.004	CcSEcCtD
Metaxalone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.004	0.004	CcSEcCtD
Metaxalone—Headache—Etoposide—peripheral nervous system neoplasm	0.00397	0.00397	CcSEcCtD
Metaxalone—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00396	0.00396	CcSEcCtD
Metaxalone—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00392	0.00392	CcSEcCtD
Metaxalone—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.0039	0.0039	CcSEcCtD
Metaxalone—Nausea—Etoposide—peripheral nervous system neoplasm	0.00377	0.00377	CcSEcCtD
Metaxalone—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00361	0.00361	CcSEcCtD
Metaxalone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00356	0.00356	CcSEcCtD
Metaxalone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00329	0.00329	CcSEcCtD
Metaxalone—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00316	0.00316	CcSEcCtD
Metaxalone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00292	0.00292	CcSEcCtD
Metaxalone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00262	0.00262	CcSEcCtD
Metaxalone—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00252	0.00252	CcSEcCtD
Metaxalone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00242	0.00242	CcSEcCtD
Metaxalone—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00235	0.00235	CcSEcCtD
Metaxalone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Metaxalone—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Metaxalone—Rash—Epirubicin—peripheral nervous system neoplasm	0.00224	0.00224	CcSEcCtD
Metaxalone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00224	0.00224	CcSEcCtD
Metaxalone—Headache—Epirubicin—peripheral nervous system neoplasm	0.00223	0.00223	CcSEcCtD
Metaxalone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Metaxalone—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00211	0.00211	CcSEcCtD
Metaxalone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Metaxalone—Rash—Doxorubicin—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Metaxalone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Metaxalone—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Metaxalone—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
